154 related articles for article (PubMed ID: 36092349)
1. Diagnostic and prognostic potential of the novel biomarker nuclear cap binding protein subunit 2 (
Bu H; Cao T; Li X; Guo Y; Guo J; Wang Y; Sun Y; Wang D
J Gastrointest Oncol; 2022 Aug; 13(4):1782-1792. PubMed ID: 36092349
[TBL] [Abstract][Full Text] [Related]
2. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
3. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
5. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
6. The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma.
Ruan GT; Gong YZ; Zhu LC; Gao F; Liao XW; Wang XK; Zhu GZ; Liao C; Wang S; Yan L; Xie HL; Zhou X; Liu JQ; Shao MN; Gan JL
Onco Targets Ther; 2020; 13():9389-9405. PubMed ID: 33061426
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive investigation of the prognostic values and molecular mechanisms of syntaxin binding protein 5 antisense RNA 1 in patients with colon adenocarcinoma based on RNA sequencing dataset.
Wei H; Tang L; Wang J; Ni M; Liao X; Guo E
J Cancer; 2023; 14(9):1607-1622. PubMed ID: 37325053
[No Abstract] [Full Text] [Related]
8. Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Gong YZ; Ma H; Ruan GT; Zhu LC; Liao XW; Wang S; Yan L; Huang W; Huang KT; Xie H; Zhu GZ; Wang XK; Liao C; Gao F
J Cancer; 2021; 12(18):5506-5518. PubMed ID: 34405013
[No Abstract] [Full Text] [Related]
9. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
[TBL] [Abstract][Full Text] [Related]
10. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
Front Genet; 2022; 13():821826. PubMed ID: 35664320
[No Abstract] [Full Text] [Related]
11. Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis.
Ruan GT; Xie HL; Zhu LC; Ge YZ; Yan L; Liao C; Gong YZ; Shi HP
Front Genet; 2022; 13():762514. PubMed ID: 35211154
[No Abstract] [Full Text] [Related]
12. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
Miao YD; Kou ZY; Wang JT; Mi DH
World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
[TBL] [Abstract][Full Text] [Related]
13. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
14. ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer.
Jia Z; Wan X
Front Cell Dev Biol; 2022; 10():792564. PubMed ID: 35237596
[No Abstract] [Full Text] [Related]
15. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
Front Genet; 2022; 13():816173. PubMed ID: 35281843
[No Abstract] [Full Text] [Related]
16. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
Front Oncol; 2022; 12():904464. PubMed ID: 35912258
[TBL] [Abstract][Full Text] [Related]
17. High Expression of MORC2 is Associated with Poor Clinical Outcomes and Immune Infiltrates in Colon Adenocarcinoma.
Zhao P; Ning J; Huang J; Wei B; Wang Z; Huang X
Int J Gen Med; 2023; 16():4595-4615. PubMed ID: 37850194
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide RNA-sequencing dataset reveals
Liao C; Gu Z; Huang W; Gong Y; Liao X; Lin M; Zhang S
J Cancer; 2023; 14(12):2386-2398. PubMed ID: 37576398
[No Abstract] [Full Text] [Related]
19. Discovered differentially expressed lncRNA AC010973.2 can act as a diagnostic and prognostic biomarker for colon adenocarcinoma.
Liu X; Xiao C; Tan F; Yi R; Zhao X
Transl Cancer Res; 2020 Oct; 9(10):6275-6286. PubMed ID: 35117237
[TBL] [Abstract][Full Text] [Related]
20.
Yang Z; Wu H; Dai D; Yuan Y; Shao X
Iran J Public Health; 2023 Dec; 52(12):2601-2610. PubMed ID: 38435777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
